Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study

Liu J, Dong YQ, Yin J, He G, Wu X, Li J, Qiu Y, He X.

COVID-19 and nonalcoholic fatty liver disease: two intersecting pandemics

Portincasa P, Krawczyk M, Smyk W, Lammert F, Di Ciaula A.

Patterns of liver injury in COVID-19 - a German case series

Schattenberg JM, Labenz C, Wörns MA, Menge P, Weinmann A, Galle PR, Sprinzl MF.

COVID-19 pandemic: Its impact on liver disease and liver transplantation

Sahin TT, Akbulut S, Yilmaz S.

Challenges for Liver Transplantation During Recovery From the COVID-19 Pandemic: Insights and Recommendations

Niriella MA, Siriwardana RC, Perera MTPR, Narasimhan G, Chan SC, Dassanayake AS.

Hepatocellular Type II Fibrinogen Inclusions in a Patient with Severe COVID-19 and Hepatitis

Fraga M, Moradpour D, Artru F, Romailler E, Tschopp J, Schneider A, Chtioui H, Neerman-Arbez M, Casini A, Alberio L, Sempoux C.

Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement

Wong GL, Wong VW, Thompson A, Jia J, Hou J, Lesmana CRA, Susilo A, Tanaka Y, Chan WK, Gane E, Ong-Go AK, Lim SG, Ahn SH, Yu ML, Piratvisuth T, Chan HL; Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic.

Impact of Chronic Liver Disease on Outcomes of Hospitalized Patients with COVID-19: A Multicenter United States Experience

Hashemi N, Viveiros K, Redd WD, Zhou JC, McCarty TR, Bazarbashi AN, Hathorn KE, Wong D, Njie C, Shen L, Chan WW.

Treatment of Hepatocellular Carcinoma (HCC) during the COVID-19 Outbreak: The Working Group Report of JAMTT-HCC

Kudo M, Kurosaki M, Ikeda M, Aikata H, Hiraoka A, Torimura T, Sakamoto N; Japan Association of Molecular Targeted Therapy for HCC (JAMTT-HCC).

Challenges in Abdominal Organ Transplantation During the COVID-19 Pandemic

Esagian SM, Ziogas IA, Giannis D, Hayat MH, Elias N, Tsoulfas G.

Hepatic manifestations and complications of COVID-19: A systematic review and meta-analysis

Kunutsor SK, Laukkanen JA.

The impact of COVID-19 on the clinical outcome of patients with cirrhosis deserves more attention and research

Gao F, Huang ZM.

Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?

Assante G, Williams R, Youngson NA.

Letter regarding [High rates of 30-day mortality in patients with cirrhosis and COVID-19]

Medhat MA, El Kassas M.

Effect of COVID-19 on liver transplantation in KOREA

Lee JM.

Virtual empathy and liver cancer

Debes JD.

Metabolic associated fatty liver disease is associated with severity of COVID-19

Zhou YJ, Zheng KI, Wang XB, Sun QF, Pan KH, Wang TY, Ma HL, Chen YP, George J, Zheng MH.

Risk factors in patients with COVID-19 developing severe liver injury during hospitalisation

Zhan K, Liao S, Li J, Bai Y, Lv L, Yu K, Qiu L, Li C, Yuan G, Zhang A, Mei Z.

COVID-19 in an international European liver transplant recipient cohort

Becchetti C, Zambelli MF, Pasulo L, Donato MF, Invernizzi F, Detry O, Dahlqvist G, Ciccarelli O, Morelli MC, Fraga M, Svegliati-Baroni G, van Vlierberghe H, Coenraad MJ, Romero MC, de Gottardi A, Toniutto P, Del Prete L, Abbati C, Samuel D, Pirenne J, Nevens F, Dufour JF; COVID-LT group.

COVID-19 with acute cholecystitis: a case report

Ying M, Lu B, Pan J, Lu G, Zhou S, Wang D, Li L, Shen J, Shu J; From the COVID-19 Investigating and Research Team.

Management of liver diseases during the pandemic of coronavirus disease-19

Cho JY, Kim SS, Lee YS, Song DS, Lee JH, Kim JH; Korean Association for the Study of the Liver.

Characteristics of pregnant COVID-19 patients with liver injury

Deng G, Zeng F, Zhang L, Chen H, Chen X, Yin M.

Case series and review of liver dysfunction in COVID-19 patients

Kudaravalli P, Saleem SA, Ibeche B, John S.

Caught in the crossfire: hepato-bilio-pancreatic cancer surgery in the midst of COVID-19

Rompianesi G, Shankar S, Reddy S, Silva M, Soonawalla Z, Friend PJ.

COVID-19 in gastroenterology and hepatology: Living with the realities of a historic 21(st) century pandemic

Yoshida EM, Hussaini T, Alsahafi M.

Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases

Huang W, Li C, Wang Z, Wang H, Zhou N, Jiang J, Ni L, Zhang XA, Wang DW.

Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection

De Gottardi A, Fratila C, Bertoli R, Cerny A, Magenta L, Gianella P, Majno-Hurst P, Ceschi A, Vanini G, Bernasconi E.

Delivery of hepato-pancreato-biliary surgery during the COVID-19 pandemic: an European-African Hepato-Pancreato-Biliary Association (E-AHPBA) cross-sectional survey

Balakrishnan A, Lesurtel M, Siriwardena AK, Heinrich S, Serrablo A, Besselink MGH, Erkan M, Andersson B, Polak WG, Laurenzi A, Olde Damink SWM, Berrevoet F, Frigerio I, Ramia JM, Gallagher TK, Warner S, Shrikhande SV, Adam R, Smith MD, Conlon KC; E-AHPBA Scientific and Research Committee.

Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation

Alqahtani SA, Aljumah AA, Hashim A, Alenazi TH, AlJawad M, Al Hamoudi WK, Alghamdi MY.

Elevation of liver fibrosis index FIB-4 is associated with poor clinical outcomes in patients with COVID-19

Ibáñez-Samaniego L, Bighelli F, Usón C, Caravaca C, Carrillo CF, Romero M, Barreales M, Perelló C, Madejón A, Marcos AC, Albillos A, Fernández I, García-Samaniego J, Calleja JL, Bañares R.

Clinically significant portal hypertension in cirrhosis patients with COVID-19: clinical characteristics and outcomes

Liu F, Long X, Ji G, Zhang B, Zhang W, Zhang Z, Chen X.

Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: initial experience at a single center in Madrid, Spain

Loinaz C, Marcacuzco A, Fernández-Ruiz M, Caso O, Cambra F, San Juan R, Justo I, Calvo J, García-Sesma A, Manrique A, Pérez-Jacoiste Asín MA, Folgueira MD, Aguado JM, Lumbreras C.

Five recommendations for loco-regional treatments of hepatocellular carcinoma during the COVID-19 pandemic

Santambrogio R, Galfrascoli E, Zappa MA.

Negative-pressure box under continuous suction for shielding against aerosols produced by patients with COVID-19 during abdominal ultrasound-guided intervention

Tani J, Kobara H, Nishiyama N, Masaki T.

COVID-19 and the liver: overview

Amin M.

Covid-19 infection, liver injury and prognosis: a suggestion

Testino G.

Author response to Letter to the Editor: Potential implications of COVID-19 in non-alcoholic fatty liver disease

Xu L, Liu J, Lu M, Yang D, Zheng X.

Characteristics of liver function in patients with SARS-CoV-2 and chronic HBV co-infection

Zou X, Fang M, Li S, Wu L, Gao B, Gao H, Ran X, YiBian, Li R, Yu S, Ling J, Li D, Tian D, Huang J.

Clinical features and outcomes of coronavirus disease 2019 (COVID-19) patients with chronic Hepatitis B virus infection

Zhang B, Huang W, Zhang S.

Hepatic manifestations and impact of COVID-19 on the cirrhotic patient

Velarde-Ruiz Velasco JA, García-Jiménez ES, Remes-Troche JM.

Impact of Pre-existing Chronic Liver Disease on the Outcome of Patients with COVID-19 Disease

Verma N, Duseja A, Singh V.

COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine

Siniscalchi M, Zingone F, Savarino EV, D'Odorico A, Ciacci C.

Delivery of care remotely through telemedicine in celiac disease: Thinking beyond COVID-19: Commentary on: DLD-20-556R1 "COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine" by Siniscalchi M et al

Ines Pinto-Sanchez M, Lebwohl B.

COVID-19 and Liver

Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M.

Converging pandemics: implications of COVID-19 for the viral hepatitis response in sub-Saharan Africa

Gupta N, Desalegn H, Ocama P, Lacombe K, Njouom R, Afihene M, Cunha L, Spearman CW, Sonderup MW, Kateera F.

Drinking alone: COVID-19, lockdown, and alcohol-related harm

The Lancet Gastroenterology Hepatology.

Pathological Findings of Postmortem Biopsies From Lung, Heart, and Liver of 7 Deceased COVID-19 Patients

Beigmohammadi MT, Jahanbin B, Safaei M, Amoozadeh L, Khoshavi M, Mehrtash V, Jafarzadeh B, Abdollahi A.

Subtotal laparoscopic cholecystectomy for gangrenous gallbladder during recovery from COVID-19 pneumonia

Lovece A, Asti E, Bruni B, Bonavina L.

Liver injury without liver failure in COVID-19 patients: how to explain, in some cases, elevated ammonia without hepatic decompensation

Honore PM, Barreto Gutierrez L, Kugener L, Redant S, Attou R, Gallerani A, De Bels D.

COVID-19 in a patient with severe asthma treated with Omalizumab

Lommatzsch M, Stoll P, Christian Virchow J.

COVID 19 infection requires strengthening of the chronic care model: the impact on liver transplant practice at a high-volume center in Italy

De Simone P, Melandro F, Balzano E, Tincani G, Catalano G, Ghinolfi D, Ducci J, Carrai P, Petruccelli S, Biancofiore G.

Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19

Sharma P, Kumar A.

COVID 19: Management of Decompensated Cirrhosis and Liver Transplant Recipients

Rosenblatt R, Verna EC.

Chronic Liver Disease and COVID-19: Alcohol Use Disorder/Alcohol-Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis

Kushner T, Cafardi J.

Telemedicine and Telehepatology During the COVID-19 Pandemic

Fix OK, Serper M.

Risk of hepatic failure in COVID-19 patients. A systematic review and meta-analysis

Samidoust P, Samidoust A, Samadani AA, Khoshdoz S.

Intestinal ischemia in the COVID-19 era

Norsa L, Valle C, Morotti D, Andrea BP, Indriolo A, Aurelio S.

COVID-19 in a Patient with Liver Cirrhosis

Kreivenaite E, Gedgaudas R, Valantiene I, Mickiene A, Kupcinskas J.

Abnormal Liver Function Tests of Patients with Coronavirus Disease 2019 in Mainland China: A Systematic Review and Meta- Analysis

Xin S, Xu J, Yu Y.

Clinical Insights for Gastroenterology and Hepatology Providers during the COVID-19 Pandemic

Gheorghe C.

COVID-19 and the liver-related deaths to come

Pawlotsky JM.

Will the COVID-19 pandemic affect HCV disease burden?

Kondili LA, Marcellusi A, Ryder S, Craxì A.

Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns

Festa S, Aratari A, De Biasio F, Fascì-Spurio F, Papi C.

Fecal Calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak

Younes C.

High rates of 30-day mortality in patients with cirrhosis and COVID-19

Iavarone M, D'Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, Perricone G, Massironi S, Spinetti A, Buscarini E, Viganò M, Carriero C, Fagiuoli S, Aghemo A, Belli LS, Lucà M, Pedaci M, Rimondi A, Rumi MG, Invernizzi P, Bonfanti P, Lampertico P.

Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19

Piano S, Dalbeni A, Vettore E, Benfaremo D, Mattioli M, Gambino CG, Framba V, Cerruti L, Mantovani A, Martini A, Luchetti MM, Serra R, Cattelan A, Vettor R, Angeli P; COVID-LIVER study group.

A letter of solidarity during the COVID-19 Pandemic

Lazarus JV, Negro F, El-Sayed M, Colombo M.

Hepatocellular Carcinoma (HCC) in the COVID-19 era: Primetime for Stereotactic Body Radiotherapy and a lesson for the future?

Scorsetti M, Goodman KA, Seong J, Loi M, Huguet F, Dawson LA.

Aspartate aminotransferase: a prognostic marker rather than a specific liver injury marker in COVID-19

Li G.

Telephone-based postoperative surveillance protocol for hepatobiliary cancer during the COVID-19 outbreak

Russolillo N, Sperti E, Ferrero A.

Low incidence of COVID-19 in children and adolescent post-liver transplant at a Latin American reference center

Tannuri U, Tannuri ACA, Cordon MNA, Miyatani HT.

The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists

Kabaçam G, Dayangaç M, Üçbilek E, Erçin CN, Günsar F, Akyıldız M, Akarsu M, Demir M, Kaymakoğlu S, Karasu Z, İdilman R.

Coronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience

Akdur A, Karakaya E, Ayvazoglu Soy EH, Alshalabi O, Kirnap M, Arslan H, Ulubay G, Hekimoglu K, Moray G, Haberal M.

Between Fear and Courage: Attitudes, Beliefs, and Behavior of Liver Transplantation Recipients and Waiting List Candidates during the COVID-19 Pandemic

Reuken PA, Rauchfuss F, Albers S, Settmacher U, Trautwein C, Bruns T, Stallmach A.

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same

Olry A, Meunier L, Délire B, Larrey D, Horsmans Y, Le Louët H.

A web-based group treatment for patients with alcoholic liver diseases at the time of the COVID-19 pandemic

Bossi MM, Tufoni M, Zaccherini G, Antognoli A, Domenicali M, Caraceni P.

Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective

Barry A, Apisarnthanarax S, O'Kane GM, Sapisochin G, Beecroft R, Salem R, Yoon SM, Lim YS, Bridgewater J, Davidson B, Scorsetti M, Solbiati L, Diehl A, Schuffenegger PM, Sham JG, Cavallucci D, Galvin Z, Dawson LA, Hawkins MA.

Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases

Zhang H, Liao YS, Gong J, Liu J, Xia X, Zhang H.

Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey

Marasco G, Nardone OM, Maida M, Boskoski I, Pastorelli L, Scaldaferri F; Italian Association of Young Gastroenterologist and Endoscopist (AGGEI).

Hepatic consequences of COVID-19 infection. Lapping or biting?

Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A.

Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients

Wang Q, Zhao H, Liu LG, Wang YB, Zhang T, Li MH, Xu YL, Gao GJ, Xiong HF, Fan Y, Cao Y, Ding R, Wang JJ, Cheng C, Xie W.

Living donor liver transplants for sick recipients during COVID-19 pandemic- An experience from a tertiary center in India

Verma S, Aleen Agarwal S, Chikkala BR, Dey R, Singh S, Varma S, Yadav V, Das D, Goyal S, Pandey VK, Nasa V, Madan K, Shweta S, Tarai B, Gupta S.

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19

Targher G, Mantovani A, Byrne CD, Wang XB, Yan HD, Sun QF, Pan KH, Zheng KI, Chen YP, Eslam M, George J, Zheng MH.

COVID-19 in liver transplant recipients: preliminary data from the ELITA/ELTR registry

Belli LS, Duvoux C, Karam V, Adam R, Cuervas-Mons V, Pasulo L, Loinaz C, Invernizzi F, Patrono D, Bhoori S, Ciccarelli O, Morelli MC, Castells L, Lopez-Lopez V, Conti S, Fondevila C, Polak W.

Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor

Gambato M, Burra P.

SARS-CoV-2: is the liver merely a bystander to severe disease?

Bangash MN, Patel JM, Parekh D, Murphy N, Brown RM, Elsharkawy AM, Mehta G, Armstrong MJ, Neil D.

COVID-19 Infection in Early Post-Operative Period after Liver Transplantation

Massoumi H, Rocca J, Frager S, Kinkhabwala M.

Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?

Anugwom CM, Aby ES, Debes JD.

Kinetic patterns of liver enzyme elevation with COVID-19 in the USA

Da BL, Mitchell RA, Lee BT, Perumalswami P, Im GY, Agarwal R, Schiano TD, Dieterich D, Saberi B.

Coronavirus Disease 2019 in an Orthotopic Liver Transplant Recipient Living with Human Immunodeficiency Virus

Modi AR, Koval CE, Taege AJ, Modaresi Esfeh J, Eghtesad B, Menon KVN, Quintini C, Miller C.

One world, one pandemic, many guidelines: management of liver diseases during COVID-19

Bollipo S, Kapuria D, Rabiee A, Ben-Yakov G, Lui RN, Lee HW, Kumar G, Siau K, Turnes J, Dhanasekaran R.

Lipase Elevation in Patients With COVID-19

McNabb-Baltar J, Jin DX, Grover AS, Redd WD, Zhou JC, Hathorn KE, McCarty TR, Bazarbashi AN, Shen L, Chan WW.

Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry?

Meszaros M, Meunier L, Morquin D, Klouche K, Fesler P, Malezieux E, Makinson A, le Moing V, Reynes J, Pageaux GP.

COVID emergency: an opportunity to increase the interaction between hepatologist and primary care physician

Casella G, Ingravalle F, Ingravalle A, Monti C, Bonetti F, Limonta A.

Recovery from COVID-19 following Hepatitis C, Human Immunodeficiency Virus Infection and Liver Transplantation

Müller H, Kniepeiss D, Stauber R, Schrem H, Rauter M, Krause R, Schemmer P.

Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19

McRae MP, Simmons GW, Christodoulides NJ, Lu Z, Kang SK, Fenyo D, Alcorn T, Dapkins IP, Sharif I, Vurmaz D, Modak SS, Srinivasan K, Warhadpande S, Shrivastav R, McDevitt JT.

Managing Acute Portal Hypertensive Gastropathy Bleed During the Time of COVID-19 Pandemic: Novelty or Necessity?

Philips CA, Kumbar S, Ahamed R, Augustine P.

Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic

Lau G, Ward JW.

Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay

Gu X, Li X, An X, Yang S, Wu S, Yang X, Wang H.

SARS-CoV-2 Infection and the Liver

Morgan K, Samuel K, Vandeputte M, Hayes PC, Plevris JN.

Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study

Hao SR, Zhang SY, Lian JS, Jin X, Ye CY, Cai H, Zhang XL, Hu JH, Zheng L, Zhang YM, Jia HY, Yu GD, Wang XY, Gu JQ, Lu YF, Yu XP, Yu L, Xiang DR, Ye CY, Jin CL, Qiu YQ, Li LJ, Sheng JF, Liang TB, Yang YD.

Atypical presentations of coronavirus disease 2019 in a patient with acute obstructive suppurative cholangitis

Zhai LL, Xiang F, Wang W, Wu L, Ye L, Yao LC, Tang ZG.

Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology

Arrese M.

Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study

Rigamonti C, Cittone MG, De Benedittis C, Rizzi E, Casciaro GF, Bellan M, Sainaghi PP, Pirisi M.

First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19

Muhović D, Bojović J, Bulatović A, Vukčević B, Ratković M, Lazović R, Smolović B.

Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review

Cha MH, Regueiro M, Sandhu DS.

Liver diseases in COVID-19: Etiology, treatment and prognosis

Wu J, Song S, Cao HC, Li LJ.

An updated meta-analysis of AST and ALT levels and the mortality of COVID-19 patients

Wang Y, Shi L, Wang Y, Yang H.

Reply to "Coronaviruses and immunosuppressed patients. The facts during the third epidemic"

Merli M, Perricone G, Lauterio A, Prosperi M, Travi G, Roselli E, Petrò L, De Carlis L, Belli L, Puoti M.

Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis

Kunutsor SK, Laukkanen JA.

Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort

Phipps MM, Barraza LH, LaSota ED, Sobieszczyk ME, Pereira MR, Zheng EX, Fox AN, Zucker J, Verna EC.

Liver tests abnormalities in COVID-19: trick or treat?

Vespa E, Pugliese N, Piovani D, Capogreco A, Danese S, Aghemo A; Humanitas Covid-19 Task Force.

Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?

Ali N.

Low prevalence and disease severity of COVID-19 in post liver transplant recipients - a single centre experience

Verma A, Khorsandi SE, Dolcet A, Prachalias A, Suddle A, Heaton N, Jassem W.

The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing

Palmer K, Monaco A, Kivipelto M, Onder G, Maggi S, Michel JP, Prieto R, Sykara G, Donde S.

SARS-CoV-2 related liver impairment - perception may not be the reality

Philips CA, Ahamed R, Augustine P.

An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise

Chew CA, Iyer SG, Chieh Kow AW, Madhavan K, Teng Wong AS, Halazun KJ, Battula N, Scalera I, Angelico R, Farid S, Buchholz BM, Rotellar F, Chi-Yan Chan A, Kim JM, Wang CC, Pitchaimuthu M, Reddy MS, Soin AS, Derosas C, Imventarza O, Isaac J, Muiesan P, Mirza DF, Bonney GK.

Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis

Zeng G, Gill US, Kennedy PTF.

Liver injury in COVID-19: The current evidence

Alqahtani SA, Schattenberg JM.

A Local Response to COVID-19 for Advanced Liver Disease: Current Model of Care, Challenges and Opportunities

Serper M, Shaked A, Olthoff KM, Hoteit M, Appolo B, Reddy KR.

Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations

APASL Covid-19 Task Force, Lau G, Sharma M.

Lack of genetic evidence that fatty liver disease predisposes to COVID-19

Valenti L, Jamialahmadi O, Romeo S.

COVID-19 and Liver Dysfunction: a systematic review and meta-analysis of retrospective studies

Youssef M, Hussein M, Attia AS, Elshazli R, Omar M, Zora G, Farhoud A, Elnahla A, Shihabi A, Toraih E, Fawzy M, Kandil E.

Pediatric Endoscopy in the Era of Coronavirus Disease 2019: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper

Walsh CM, Fishman DS, Lerner DG; NASPGHAN Endoscopy and Procedures Committee#.

COVID-19-A Guide to Rapid Implementation of Telehealth Services: A Playbook for the Pediatric Gastroenterologist

Berg EA, Picoraro JA, Miller SD, Srinath A, Franciosi JP, Hayes CE, Farrell PR, Cole CR, LeLeiko NS.

Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition

Turner D, Huang Y, Martín-de-Carpi J, Aloi M, Focht G, Kang B, Zhou Y, Sanchez C, Kappelman MD, Uhlig HH, Pujol-Muncunill G, Ledder O, Lionetti P, Dias JA, Ruemmele FM, Russell RK; Paediatric IBD Porto group of ESPGHAN.

COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter

Lee BT, Perumalswami PV, Im GY, Florman S, Schiano TD.

Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China

Qi X, Wang J, Li X, Wang Z, Liu Y, Yang H, Li X, Shi J, Xiang H, Liu T, Kawada N, Maruyama H, Jiang Z, Wang F, Takehara T, Rockey DC, Sarin SK; COVID-Cirrhosis-CHESS Group.

Liver transplantation in the era of COVID-19

El Kassas M, Alboraie M, Al Balakosy A, Abdeen N, Afify S, Abdalgaber M, Sherief AF, Madkour A, Abdellah Ahmed M, Eltabbakh M, Salaheldin M, Wifi MN.

COVID-19 and Liver Transplantation: lessons learned from three reported cases

Gao F, Zheng KI, Gu JY, George J, Zheng MH.

Reply to: 'Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis'

Ji D, Qin E, Lau G.

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, Li X, Xu P, Zhang L, Zhao L, Cao Y, Kang J, Yang J, Li L, Liu X, Li Y, Nie R, Mu J, Lu F, Zhao S, Lu J, Zhao J.

Hepatic complications of COVID-19 and its treatment

Tian D, Ye Q.

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

Gao F, Zheng KI, Wang XB, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, George J, Zheng MH.

Surgical resection for liver cancer during the COVID-19 outbreak

Triki H, Jeddou H, Boudjema K.

Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study

Qi X, Liu Y, Wang J, Fallowfield J, Wang J, Li X, Shi J, Pan H, Zou S, Zhang H, Chen Z, Li F, Luo Y, Mei M, Liu H, Wang Z, Li J, Yang H, Xiang H, Li X, Liu T, Zheng MH, Liu C, Huang Y, Xu D, Li X, Kang N, He Q, Gu Y, Zhang G, Shao C, Liu D, Zhang L, Li X, Kawada N, Jiang Z, Wang F, Xiong B, Takehara T, Rockey DC; COVID-Cirrhosis-CHESS Group.

COVID-19 and liver cancer clinical trials: not everything is lost

D'Alessio A, Personeni N, Pressiani T, Bozzarelli S, Smiroldo V, Simonelli M, Lleo A, Santoro A, Rimassa L.

Pancreaticobiliary Endoscopy in the COVID-19 Pandemic Era

Machicado JD, Papachristou GI, Cote GA, Wani S, Groce JR, Conwell DL, Krishna SG.

Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis

Oyelade T, Alqahtani J, Canciani G.

The liver in times of COVID-19: What hepatologists should know

Ridruejo E, Soza A.

Redesign of a GI endoscopy unit during the COVID-19 emergency: A practical model

Cennamo V, Bassi M, Landi S, Apolito P, Ghersi S, Dabizzi E, Polifemo AM, Gizzi G, Guicciardi S, Indelicato G, Cascone C, Tovoli D, Tumietto F, Viale P, Jovine E, Repici A.

"Impact of the COVID-19 pandemic on Gastroenterology Divisions in Italy: a national survey"

Maida M, Sferrazza S, Savarino E, Ricciardiello L, Repici A, Morisco F, Furnari M, Fuccio L, Morreale GC, Vitello A, Burra P, Marchi S, Annibale B, Benedetti A, Alvaro D, Ianiro G; Italian Society of Gastroenterology (SIGE).

ANALYSIS OF PATIENTS ATTITUDE TO UNDERGO URGENT ENDOSCOPIC PROCEDURES DURING COVID-19 OUTBREAK IN ITALY

Armellini E, Repici A, Alvisi C, Dinelli M, Gambitta P, Manes G, Mutignani M, Orlando S, Radaelli F, Salerno R, Venezia G, Verna C, Penagini R, Pace F; Fast Track Endoscopy Study Group.

COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine: COVID-19 and CeD

Siniscalchi M, Zingone F, Savarino EV, D'Odorico A, Ciacci C.

A negative fallout of COVID-19 lockdown in Italy: life-threatening delay in the diagnosis of celiac disease

Catassi GN, Vallorani M, Cerioni F, Lionetti E, Catassi C.

COVID-19 related liver injury: call for international consensus

Ye Z, Song B.

We know liver biochemistries are elevated in COVID-19, but should we be concerned?

Bloom PP, Pasricha TS, Viveiros K.

No Need of Transforming Gastroenterology Units to COVID Units at the Time of SARS-COV2 Infection - A Single-Center Analysis from Northern Italy

Zingone F, Casadei C, Farinati F, Savarino E.

The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis

Wang H, Qiu P, Liu J, Wang F, Zhao Q.

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)

Di Fiore F, Bouché O, Lepage C, Sefrioui D, Gangloff A, Schwarz L, Tuech JJ, Aparicio T, Lecomte T, Boulagnon-Rombi C, Lièvre A, Manfredi S, Phelip JM, Michel P; Thésaurus National de Cancérologie Digestive (TNCD); Société Nationale Française de Gastroentérologie (SNFGE); Fédération Francophone de Cancérologie Digestive (FFCD); Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR); Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER); Société Française de

Management of Hepatocellular Cancer in the time of SARS-CoV-2.

Sharma R, Pinato DJ.

Liver Biochemistries in Hospitalized Patients With COVID-19.

Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RT.

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.

Targher G, Mantovani A, Byrne CD, Wang XB, Yan HD, Sun QF, Pan KH, Zheng KI, Chen YP, Eslam M, George J, Zheng MH.

Health status of patients with Autoimmune Liver Disease during SARS-CoV-2 outbreak in northern Italy.

Coronavirus Disease 2019 and Viral Hepatitis coinfection: Provide guidelines for integrated screening and treatment.

Odjidja EN, Longo VL, Rizzatti G, Bandoh S.

COVID-19: an overview of worldwide recommendations for management of patients with liver diseases or liver transplantation.

AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.

Clinical Characteristics of COVID-19 in Patients With Liver Injury.

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.

Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, Shen J, Zhu LR, Chen Y, Iacucci M, Ng SC, Ghosh S, Chen MH.

Gastrointestinal and Liver Manifestations of COVID-19.

Child with liver transplant recovers from COVID-19 infection. A case report.

Review article: COVID-19 and liver disease - what we know on 1st May 2020".

Garrido I, Liberal R, Macedo G.

A case of coronavirus disease 2019-infected liver transplant donor.

Hong HL, Kim SH, Choi DL, Kwon HH.

Liver injury in COVID-19: diagnosis and associated factors - authors' reply.

Lian N, Lin S, Xie H.

Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19.

Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies.

Parohan M, Yaghoubi S, Seraj A.

Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs.

Agnes S, Andorno E, Avolio AW, Baccarani U, Carraro A, Cescon M, Cillo U, Colledan M, De Carlis L, De Simone P, De Ville De Goyet J, Di Benedetto F, Ettorre GM, Gringeri E, Gruttadauria S, Lupo LG, Mazzaferro V, Regalia E, Romagnoli R, Rossi GE, Rossi M, Spada M, et al.

Acute on Chronic Liver Failure from Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Qiu H, Wander P, Bernstein D, Satapathy SK.

COVID-19 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease.

Da BL, Im GY, Schiano TD.

Changes in liver transplant center practice in response to COVID-19: Unmasking dramatic center-level variability.

Agopian V, Verna E, Goldberg D.

Hepatic involvement in COVID-19 patients: pathology, pathogenesis and clinical implications [Review].

Li Y, Xiao SY.

Liver injury in critically ill patients with COVID-19: a case series.

Cardoso FS, Pereira R, Germano N.

Liver injury in COVID-19: diagnosis and associated factors.

Ye Z, Song B.

Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy: A Case Report.

Hammami MB, Garibaldi B, Shah P, Liu G, Jain T, Chen PH, Kim AK, Avdic E, Petty B, Strout S, Fine DM, Niranjan-Azadi A, Garneau WM, Cameron AM, Monroy Trujillo JM, Gurakar A, Avery R.

Longitudinal association between markers of liver injury and mortality in COVID-19 in China.

Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L, Zhang XJ, Cai J, Lin L, Ouyang S, Wang X, Yang C, Cheng X, Liu W, Li H, Xie J, Wu B, Luo H, Xiao F, Chen J, Tao L, Cheng G, et al.

SARS-CoV-2 virus and liver expression of host receptors: Putative mechanisms of liver involvement in COVID-19.

Pirola CJ, Sookoian S.

Author response to Letter to the Editor "Liver impairment associated with disease progression in COVID-19 patients".

Zhang Y, Liu L, Zhao Q.

How to guarantee liver transplantation in the north of Italy during the COVID-19 pandemic. A sound transplant protection strategy.

Lauterio A, De Carlis R, Belli L, Fumagalli R, De Carlis L.

[Management of gastrointestinal and hepatic diseases during the COVID-19 outbreak].

Restellini S, Buyse S, Godat S, Goossens N, Maillard MH.

ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection.

Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z.

HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN.

Donato MF, Invernizzi F, Lampertico P, Rossi G.

SARS-Cov-2 (human) and COVID-19: Primer 2020.

Ramakrishna G, Kumar P, Aggarwal S, Islam M, Singh R, Jagdish RK, Trehanpati N.

Management of hepatocellular carcinoma in the time of COVID-19.

Iavarone M, Sangiovanni A, Carrafiello G, Rossi G, Lampertico P.

The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy.

Maggi U, De Carlis L, Yiu D, Colledan M, Regalia E, Rossi G, Angrisani M, Consonni D, Fornoni G, Piccolo G, DeFeo TM.

The impact of Covid-19 0n Head and Neck Surgery, Education and training.

Shah JP.

Severe liver failure during SARS-CoV-2 infection.

Weber S, Mayerle J, Irlbeck M, Gerbes AL.

Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.

Zheng KI, Gao F, Wang XB, Sun QF, Pan KH, Wang TY, Ma HL, Liu WY, George J, Zheng MH.

COVID-19 and viral hepatitis elimination programs: Are we stepping backward?

Karimi-Sari H, Rezaee-Zavareh MS.

Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with Novel Coronavirus Disease (COVID-19).

Falcão MB, Pamplona de Góes Cavalcanti L, Filgueiras Filho NM, Antunes de Brito CA.

What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective.

Méndez-Sánchez N, Valencia-Rodríguez A, Qi X, Yoshida EM, Romero-Gómez M, George J, Eslam M, Abenavoli L, Xie W, Teschke R, Carrion AF, Keaveny AP.

Potential implications of COVID-19 in non-alcoholic fatty liver disease.

Prins GH, Olinga P.

Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury.

Qi X, Liu C, Jiang Z, Gu Y, Zhang G, Shao C, Yue H, Chen Z, Ma B, Liu D, Zhang L, Wang J, Xu D, Lei J, Li X, Huang H, Wang Y, Liu H, Yang J, Pan H, Liu W, Wang W, et al.

Bilirubin levels in patients with mild and severe Covid-19: a pooled analysis.

Paliogiannis P, Zinellu A.

Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids.

Zhao B, Ni C, Gao R, Wang Y, Yang L, Wei J, Lv T, Liang J, Zhang Q, Xu W, Xie Y, Wang X, Yuan Z, Liang J, Zhang R, Lin X.

COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation.

Lagana SM, De Michele S, Lee MJ, Emond JC, Griesemer AD, Tulin-Silver SA, Verna EC, Martinez M, Lefkowitch JH.

COVID-19 Presenting as Acute Hepatitis.

Wander P, Epstein M, Bernstein D.

COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care.

Tapper EB, Asrani SK.

Characteristics of Liver Tests in COVID-19 Patients.

Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, Li Z, Zhou G, Gou J, Qu J, Sun Y, Liu Y, He Q, Chen J, Liu L, Xu L.

Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.

Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan DC, Pratt DS, Russo MW, Schilsky ML, Verna EC, Loomba R, Cohen DE, Bezerra JA, Reddy KR, Chung RT.

Liver impairment associated with disease progression in COVID-19 patients.

Chen P, Lei J, Wu Y, Liu G, Zhou B.

Covid-19 and cancer patients: Choosing wisely is the key.

Cannizzaro R, Puglisi F.

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.

Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, Berg T.

A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic.

Bloom PP.

Clinical Features of COVID-19-Related Liver Damage.

Fan Z, Chen L, Li J, Cheng X, Jingmao Yang, Tian C, Zhang Y, Huang S, Liu Z, Cheng J.

Highlights for management of patients with Autoimmune Liver Disease during COVID-19 pandemia.

Lleo A, Invernizzi P, Lohse AW, Aghemo A, Carbone M.

COVID-19 and the liver: the perils of non-peer reviewed science in times of a pandemic.

Debes JD.

COVID-19: Thoughts and comments from a Tertiary Liver Transplant Center in France.

Tzedakis S, Jeddou H, Houssel-Debry P, Sulpice L, Boudjema K.

Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis.

Lippi G, de Oliveira MHS, Henry BM.

Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis.

Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, Lau G.

Fatal outcome in a liver transplant recipient with COVID-19.

Huang JF, Zheng KI, George J, Gao HN, Wei RN, Yan HD, Zheng MH.

Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.

Liu H, He X, Wang Y, Zhou S, Zhang D, Zhu J, He Q, Zhu Z, Li G, Sun L, Wang J, Cheng G, Liu Z, Lau G.

Challenges in paediatric inflammatory bowel diseases in the COVID-19 time.

Dipasquale V, Cucchiara S, Martinelli M, Miele E, Aloi M, Romano C.

Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?

Serper M, Cubell AW, Deleener ME, Casher TK, Rosenberg DJ, Whitebloom D, Rosin RM.

COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies.

Feng G, Zheng KI, Yan QQ, Rios RS, Targher G, Byrne CD, Poucke SV, Liu WY, Zheng MH.

Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.

Li J, Fan JG.

[Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].

Qian ZP, Mei X, Zhang YY, Zou Y, Zhang ZG, Zhu H, Guo HY, Liu Y, Ling Y, Zhang XY, Wang JF, Lu HZ.

Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI).

Saigal S, Gupta S, Sudhindran S, Goyal N, Rastogi A, Jacob M, Raja K, Ramamurthy A, Asthana S, Dhiman RK, Singh B, Perumalla R, Malik A, Shanmugham N, Soin AS.

COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?

Boeckmans J, Rodrigues RM, Demuyser T, Piérard D, Vanhaecke T, Rogiers V.

COVID-19 and liver disease.

Sun J, Aghemo A, Forner A, Valenti L.

Liver transplantation in an ICU dominated by COVID-19.

Cardoso FS.

Successful Treatment of Severe COVID-19 Pneumonia in a Liver Transplant Recipient.

Bin L, Yangzhong W, Yuanyuan Z, Huibo S, Fanjun Z, Zhishui C.

Gastrointestinal and Liver Manifestations in Patients with COVID-19.

Lee IC, Huo TI, Huang YH.

Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China.

Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q.

Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study.

Xie H, Zhao J, Lian N, Lin S, Xie Q, Zhuo H.

Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient.

Qin J, Wang H, Qin X, Zhang P, Zhu L, Cai J, Yuan Y, Li H.

Coronaviruses and immunosuppressed patients. The facts during the third epidemic.

D'Antiga L.

Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor.

Rismanbaf A, Zarei S.

Liver injury during highly pathogenic human coronavirus infections.

Xu L, Liu J, Lu M, Yang D, Zheng X.

[Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region].

Yao N, Wang SN, Lian JQ, Sun YT, Zhang GF, Kang WZ, Kang W.

[Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of novel coronavirus pneumonia].

Wu F, Song Y, Zeng HY, Ye F, Rong WQ, Wang LM, Wu JX.

[Treatment strategies of Budd-Chiari syndrome during the epidemic period of 2019 coronavirus disease].

Li LH, Zhang G, Dang XW, Li L.

[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].

Liu C, Jiang ZC, Shao CX, Zhang HG, Yue HM, Chen ZH, Ma BY, Liu WY, Huang HH, Yang J, Wang Y, Liu HY, Xu D, Wang JT, Yang JY, Pan HQ, Zou SQ, Li FJ, Lei JQ, Li X, He Q, Gu Y, et al.

[Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia].

Guan GW, Gao L, Wang JW, Wen XJ, Mao TH, Peng SW, Zhang T, Chen XM, Lu FM.

[Novel coronavirus pneumonia related liver injury: etiological analysis and treatment strategy].

Hu LL, Wang WJ, Zhu QJ, Yang L.